Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis

被引：5
|
作者：
Lelong, Margaux [1 ]
Raoul, Jean-Luc [1 ]
Touchefeu, Yann [2 ]
Berthelot, Jean-Marie [3 ]
Arnolfo, Paul [3 ]
Matysiak-Budnik, Tamara [2 ]
Senellart, Helene [1 ]
机构：
[1] Inst Cancerol Ouest, Dept Med Oncol, Blvd Prof Jacques MONOD, F-44805 St Herblain, France
[2] Univ Hosp, Dept Gastroenterol, IMAD, Nantes, France
[3] Univ Hosp, Dept Rhumatol, Nantes, France
来源：
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词：
BRCA mutation; lipase; long survival; pancreatic acinar cell cancer; panniculitis;
D O I：
10.1002/ccr3.6718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This 38-year-old man has a familial BRCA2 mutation. He presented with skin erythema, polyarthritis, dactylitis, and febrile erythema nodosum; a biopsy of a liver metastase revealed acinar cell carcinoma of the pancreas. After FOLFIRINOX, olaparib was initiated, and 24 months after, the patient was PS 0 and asymptomatic.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Pathogenic germline mutations in BRCA1, BRCA2 and CHEK2 in a single patient with pancreatic acinar cell carcinoma
    Fischer, A.
    Jahn, A.
    Hackmann, K.
    Zeugner, S.
    Riedmann, K.
    Pfarr, N.
    Grabmeier, A.
    Aust, D.
    Rump, A.
    Schroeck, E.
    Gieldon, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1592 - 1593
  • [42] Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis
    Exman, Pedro
    Mallery, Robert M.
    Lin, Nancy U.
    Parsons, Heather A.
    NPJ BREAST CANCER, 2019, 5 (1)
  • [43] Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis
    Pedro Exman
    Robert M. Mallery
    Nancy U. Lin
    Heather A. Parsons
    npj Breast Cancer, 5
  • [44] Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
    Costa, Bruno Almeida
    de Lara, Paulino Tallon
    Park, Wungki
    Keane, Fergus
    Harding, James J.
    Khalil, Danny N.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (05) : 211 - 215
  • [45] POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)
    Hammel, P.
    Kindler, H. L.
    Reni, M.
    Van Cutsem, E.
    Macarulla Mercade, T.
    Hall, M. J.
    Park, J. O.
    Hochhauser, D.
    Arnold, D.
    Oh, D-Y.
    Reinacher-Schick, A.
    Tortora, G.
    Alguel, H.
    O'Reilly, E. M.
    McGuinness, D.
    Cui, K. Y.
    Joo, S.
    Yoo, H. K.
    Patel, N.
    Golan, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 254 - 255
  • [46] Hepatic artery ligation for liver metastases of a pancreatic acinar cell carcinoma revealed by a nodular panniculitis.
    Viguier, J
    D'Alteroche, L
    Regimbeau, C
    Picon, L
    Jan, V
    De Muret, A
    Benchellal, ZA
    Metman, EH
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1998, 22 (8-9): : 715 - 719
  • [47] Excellent Response to Olaparib in a Patient with Metastatic Pancreatic Adenocarcinoma with Germline BRCA1 Mutation after Progression on FOLFIRINOX: Case Report and Literature Review
    Pimenta, Jefferson Rios
    Nakao Ueda, Serli Kiyomi
    Peixoto, Renata D'Alpino
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 904 - 910
  • [48] Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer
    Kindler, Hedy L.
    Yoo, Hyun Kyoo
    Hettle, Robert
    Cui, Karen Y. Y.
    Joo, Seongjung
    Locker, Gershon Y.
    Golan, Talia
    CANCER, 2023, 129 (09) : 1411 - 1418
  • [49] POLO: A randomized phase III trial of olaparib maintenance monotherapy in patients (pts) with metastatic pancreatic cancer (mPC) who have a germline BRCA1/2 mutation (gBRCAm).
    Golan, Talia
    Oh, Do-Youn
    Reni, Michele
    Macarulla, Teresa Mercade
    Tortora, Giampaolo
    Hall, Michael J.
    Reinacher-Schick, Anke C.
    Borg, Christophe
    Hochhauser, Daniel
    Walter, Thomas
    Hochster, Howard S.
    Baker, Nigel
    Locker, Gershon Y.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation
    Okada, Kenjiro
    Uemura, Kenichiro
    Okamoto, Wataru
    Sumiyoshi, Tatsuaki
    Shintakuya, Ryuta
    Otsuka, Hiroyuki
    Serikawa, Masahiro
    Ishii, Yasutaka
    Arihiro, Koji
    Takahashi, Shinya
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2023, 16 (02) : 283 - 288
12345